- Investing Ideas
- Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
0 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
UCB
Market Cap: €47.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€250.90
7D
3.1%
1Y
35.3%
argenx
Market Cap: €48.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€775.60
7D
2.3%
1Y
48.2%